Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -81.65x is 244% below its 5-year average of 56.77x, around the middle of its 5-year range (-1050.00x–901.67x).
As of the fiscal period ended Tuesday, March 31, 2026. 84.78% above its 12-month average of -536.44x.
Reported quarterly interest coverage; no daily interpolation.
INTEREST COVERAGE RATIO
-81.65x
INTEREST COVERAGE RATIO AVG TTM
-536.44x
INTEREST COVERAGE RATIO AVG 3Y
-123.08x
INTEREST COVERAGE RATIO AVG 5Y
56.77x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+84.78%
CURRENT VS 3Y AVG
+33.66%
CURRENT VS 5Y AVG
-243.81%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
6.77x
median of 73 covered companies
CURRENT VS SECTOR MEDIAN
-1306.01%
vs the sector median at left
Moderna, Inc.
Market Cap
$21.45B
Interest Coverage Ratio
-81.65x
TTM Avg
-536.44x
3Y Avg
-123.08x
5Y Avg
56.77x
Market Cap
$20.86B
Interest Coverage Ratio
18.15x
TTM Avg
14.10x
3Y Avg
10.28x
5Y Avg
10.20x
Market Cap
$22.43B
Interest Coverage Ratio
77.81x
TTM Avg
54.95x
3Y Avg
40.03x
5Y Avg
35.88x
Market Cap
$22.59B
Interest Coverage Ratio
-45.74x
TTM Avg
444.02x
3Y Avg
1201.03x
5Y Avg
1201.03x
Market Cap
$20.08B
Interest Coverage Ratio
-5.65x
TTM Avg
0.68x
3Y Avg
1.36x
5Y Avg
1.37x
Market Cap
$23.10B
Interest Coverage Ratio
1029.00x
TTM Avg
617.01x
3Y Avg
353.82x
5Y Avg
258.97x
Market Cap
$23.51B
Interest Coverage Ratio
553.04x
TTM Avg
298.73x
3Y Avg
269.07x
5Y Avg
276.66x
Market Cap
$24.34B
Interest Coverage Ratio
6.77x
TTM Avg
5.99x
3Y Avg
5.91x
5Y Avg
8.30x
Market Cap
$24.42B
Interest Coverage Ratio
12.84x
TTM Avg
11.03x
3Y Avg
12.05x
5Y Avg
13.28x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $21.45B | -81.65x | -536.44x | -123.08x | 56.77x |
| STERIS plc (STE)vs › | $20.86B | 18.15x | 14.10x | 10.28x | 10.20x |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 77.81x | 54.95x | 40.03x | 35.88x |
| BioNTech SE (BNTX)vs › | $22.59B | -45.74x | 444.02x | 1201.03x | 1201.03x |
| Viatris Inc. (VTRS)vs › | $20.08B | -5.65x | 0.68x | 1.36x | 1.37x |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 1029.00x | 617.01x | 353.82x | 258.97x |
| Incyte Corporation (INCY)vs › | $23.51B | 553.04x | 298.73x | 269.07x | 276.66x |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 6.77x | 5.99x | 5.91x | 8.30x |
| Waters Corporation (WAT)vs › | $24.42B | 12.84x | 11.03x | 12.05x | 13.28x |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 5.79x | 5.88x | 7.29x | 9.45x |
Interest Coverage
-81.6x
Debt/Equity
0.22
Current Ratio
3.29
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -81.65x |
| 2025-12-31 | -107.13x |
| 2025-06-30 | -907.00x |
| 2025-03-31 | -1050.00x |
| 2024-12-31 | -207.67x |
| 2024-09-30 | -11.67x |
| 2024-06-30 | -227.17x |
| 2024-03-31 | -211.00x |
| 2023-12-31 | 1.00x |
| 2023-09-30 | -201.20x |
| 2023-06-30 | -143.62x |
| 2023-03-31 | -40.67x |
| 2022-12-31 | 158.00x |
| 2022-09-30 | 145.75x |
| 2022-06-30 | 489.40x |
| 2022-03-31 | 704.50x |
| 2021-12-31 | 901.67x |
| 2021-09-30 | 889.50x |
| 2021-06-30 | 612.40x |
| 2021-03-31 | 422.00x |
| 2020-12-31 | -78.40x |
| 2020-09-30 | -82.96x |
| 2020-06-30 | -65.03x |
| 2020-03-31 | -78.55x |
| 2019-12-31 | -65.44x |
| 2019-09-30 | -78.92x |
| 2019-06-30 | -81.42x |
| 2019-03-31 | -92.39x |
| 2018-12-31 | -100.35x |
| 2018-03-31 | -2866.74x |
